Presentation is loading. Please wait.

Presentation is loading. Please wait.

Detailed Analysis of Prognostic Factors in Primary Esophageal Small Cell Carcinoma  Wei-Wei Chen, MD, Feng Wang, MD, PhD, ShaoBin Chen, MD, Luhua Wang,

Published by紫玚 锺 Modified over 5 years ago

Similar presentations

Presentation on theme: "Detailed Analysis of Prognostic Factors in Primary Esophageal Small Cell Carcinoma  Wei-Wei Chen, MD, Feng Wang, MD, PhD, ShaoBin Chen, MD, Luhua Wang,"— Presentation transcript:

1 Detailed Analysis of Prognostic Factors in Primary Esophageal Small Cell Carcinoma 
Wei-Wei Chen, MD, Feng Wang, MD, PhD, ShaoBin Chen, MD, Luhua Wang, MD, Chao Ren, MD, Hui-Yan Luo, MD, Feng-hua Wang, MD, PhD, Yu-Hong Li, MD, PhD, Dong-Sheng Zhang, MD, PhD, Rui-Hua Xu, MD, PhD  The Annals of Thoracic Surgery  Volume 97, Issue 6, Pages (June 2014) DOI: /j.athoracsur Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Kaplan-Meier survival curves. (A) Patients with diagnoses of small cell carcinoma of the esophagus. (B) Patients without lymph node involvement had better survival than those with lymph node metastases (28.0 vs 9.5, p < 0.001). (C) Patients with distant metastases had inferior MST compared with patients with localized lesions (8.8 vs 16.8 months, p < 0.001). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Kaplan-Meier survival curves. (A) Survival of patients who received surgical treatment versus that of patients who did not in subset I/IIA. (B) Survival of patients who received surgical treatment and chemotherapy (1 induction chemotherapy and 23 adjuvant chemotherapy) versus that of patients who received surgical treatment alone in subset I/IIA. (C) Survival of patients who received chemotherapy versus that of patients who did not in subset IIB/III. (D) Survival of patients who received radiotherapy in addition to chemotherapy (7 induction chemotherapy, 2 chemoradiotherapy, and 2 adjuvant chemotherapy) versus that of patients who received surgical treatment in combination with chemotherapy (3 induction chemotherapy and 28 adjuvant chemotherapy). (E) Survival of patients who received surgical treatment versus that of patients who did not in subset IIB/III. (F) Survival of patients who received radiotherapy versus that of patients who did not in subset IIB/III. The number of patients at risk in each group is given below the graph. (C = chemotherapy; S = surgical treatment; MST = median survival time; R = radiotherapy.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Kaplan-Meier survival curves. (A) Survival of patients who received chemotherapy versus that of patients who did not in subset IV. (B) Survival of patients who received chemotherapy and radiotherapy versus that of patients with chemotherapy alone in subset IV. (C) Survival of patients who received surgery versus that of patients without surgery in subset IV. (D) Survival of patients who received radiotherapy versus that of patients without radiotherapy in subset IV. (MST = median survival time.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Detailed Analysis of Prognostic Factors in Primary Esophageal Small Cell Carcinoma  Wei-Wei Chen, MD, Feng Wang, MD, PhD, ShaoBin Chen, MD, Luhua Wang,"

Similar presentations

Epstein-Barr Virus–Related Post-Transplantation Lymphoproliferative Disorder after Unmanipulated Human Leukocyte Antigen Haploidentical Hematopoietic.

Epstein-Barr Virus–Related Post-Transplantation Lymphoproliferative Disorder after Unmanipulated Human Leukocyte Antigen Haploidentical Hematopoietic.
Extramedullary Relapse of Acute Leukemia after Haploidentical Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, Treatment, and Clinical.

Extramedullary Relapse of Acute Leukemia after Haploidentical Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, Treatment, and Clinical.
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,
A Single-Center Analysis of the Treatment and Prognosis of Patients With Thymic Carcinoma  Yirui Zhai, MD, Zhouguang Hui, MD, Wei Ji, MD, Xiaozhen Wang,

A Single-Center Analysis of the Treatment and Prognosis of Patients With Thymic Carcinoma  Yirui Zhai, MD, Zhouguang Hui, MD, Wei Ji, MD, Xiaozhen Wang,
Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients  Ze Fen Xiao, MD, Zong Yi Yang, MD, Jun Liang, MD, Yan.

Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients  Ze Fen Xiao, MD, Zong Yi Yang, MD, Jun Liang, MD, Yan.
Association of Perioperative Fluid Balance and Adverse Surgical Outcomes in Esophageal Cancer and Esophagogastric Junction Cancer  Shenhai Wei, MD, PhD,

Association of Perioperative Fluid Balance and Adverse Surgical Outcomes in Esophageal Cancer and Esophagogastric Junction Cancer  Shenhai Wei, MD, PhD,
Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer  Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,

Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer  Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,
Collision Tumor of Esophagus: Report of Three Cases

Collision Tumor of Esophagus: Report of Three Cases
Joshua E. Rosen, BASc, Hari B

Joshua E. Rosen, BASc, Hari B
Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma  Jeeyun Lee, MD, Kyoung-Eun.

Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma  Jeeyun Lee, MD, Kyoung-Eun.
Extraesophageal Saline During Endoscopic Submucosal Dissection in a Patient With Early Esophageal Squamous Cell Carcinoma  Jian-jun Li, MD, PhD, Hong-bo.

Extraesophageal Saline During Endoscopic Submucosal Dissection in a Patient With Early Esophageal Squamous Cell Carcinoma  Jian-jun Li, MD, PhD, Hong-bo.
Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer  Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.

Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer  Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.
Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma  Giulio Melloni, MD, Claudio.

Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma  Giulio Melloni, MD, Claudio.
Epidermal Growth Factor Receptor Is a Prognosis Predictor in Patients With Esophageal Squamous Cell Carcinoma  Wencheng Zhang, MD, Hongxia Zhu, MD, Xiao.

Epidermal Growth Factor Receptor Is a Prognosis Predictor in Patients With Esophageal Squamous Cell Carcinoma  Wencheng Zhang, MD, Hongxia Zhu, MD, Xiao.
Epstein-Barr Virus–Related Post-Transplantation Lymphoproliferative Disorder after Unmanipulated Human Leukocyte Antigen Haploidentical Hematopoietic.

Epstein-Barr Virus–Related Post-Transplantation Lymphoproliferative Disorder after Unmanipulated Human Leukocyte Antigen Haploidentical Hematopoietic.
Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.
Prognostic Value of Different Lymph Node Staging Methods in Esophageal Squamous Cell Carcinoma After Esophagectomy  San-Gang Wu, MD, Feng-Yan Li, MD,

Prognostic Value of Different Lymph Node Staging Methods in Esophageal Squamous Cell Carcinoma After Esophagectomy  San-Gang Wu, MD, Feng-Yan Li, MD,

Similar presentations

Ads by Google